RT Journal Article
T1 European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis.
A1 Oosterhaven, Jart A F
A1 Uter, Wolfgang
A1 Aberer, Werner
A1 Armario-Hita, José C
A1 Ballmer-Weber, Barbara K
A1 Bauer, Andrea
A1 Czarnecka-Operacz, Magdalena
A1 Elsner, Peter
A1 García-Gavín, Juan
A1 Giménez-Arnau, Ana M
A1 John, Swen M
A1 Kręcisz, Beata
A1 Mahler, Vera
A1 Rustemeyer, Thomas
A1 Sadowska-Przytocka, Anna
A1 Sánchez-Pérez, Javier
A1 Simon, Dagmar
A1 Valiukevičienė, Skaidra
A1 Weisshaar, Elke
A1 Schuttelaar, Marie L A
A1 ESSCA Working Group, 
K1 allergic contact dermatitis
K1 body site
K1 contact allergy
K1 patch test
K1 sensitization
K1 RRID:SCR_001905
K1 Body site
K1 Eczema
K1 Epidemiology
K1 Irritant contact dermatitis
K1 Occupational contact dermatitis
K1 Patch testing
K1 Sensitization
AB Analyses of the European Surveillance System on Contact Allergies (ESSCA) database have focused primarily on the prevalence of contact allergies to the European baseline series, both overall and in subgroups of patients. However, affected body sites have hitherto not been addressed. To determine the prevalence of contact allergies for distinct body sites in patients with allergic contact dermatitis (ACD). Analysis of data collected by the ESSCA (www.essca-dc.org) in consecutively patch tested patients, from 2009 to 2014, in eight European countries was performed. Cases were selected on the basis of the presence of minimally one positive patch test reaction to the baseline series, and a final diagnosis of ACD attributed to only one body site. Six thousand two hundred and fifty-five cases were analysed. The head and hand were the most common single sites that ACD was attributed to. Differences between countries were seen for several body sites. Nickel, fragrance mix I, cobalt and methylchloroisothiazolinone/methylisothiazolinone were the most frequent allergens reported for various body sites. Distinct allergen patterns per body site were observed. However, contact allergies were probably not always relevant for the dermatitis that patients presented with. The possibility of linking positive patch test reactions to relevance, along with affected body sites, should be a useful addition to patch test documentation systems.
YR 2019
FD 2019-01-14
LK http://hdl.handle.net/10668/13285
UL http://hdl.handle.net/10668/13285
LA en
DS RISalud
RD Apr 5, 2025